Tsumura Daioubotanto : 42bags(for two weeks)
|Manufacturer||TSUMURA & CO.|
|Brand||TSUMURA & CO.|
|Shipping Schedule||about 3 weeks after payment|
TSUMURA Daiobotampito Extract Granules (hereafter TJ-33)is indicated for the relief of the following symptoms of those patients with a comparatively strong constitution and lower abdominal pain who are likely to have constipation:Menstrual irregularity, dysmen orrhea, constipation, and hemorrhoid
7.5 g (3bags for 1day) of TSUMURA Daiobotampito extract granules contains 3.5 g of a dried extract of the following mixed crude drugs.JP Benincasa Seed 6.0 gJP Peach Kernel 4.0 gJP Moutan Bark 4.0 gJP Rhubarb 2.0 gAnhydrous Mirabilitum 1.8 g(JP: The Japanese Pharmacopoeia)
TJ-33 is indicated for the relief of the following symptoms of those patients with a comparatively strong constitution and lower abdominal pain who are likely to have constipation: Menstrual irregularity, dysmenorrhea, constipation, and hemorrhoid
The usual adult dose is 7.5 g/day orally in 2 or 3 divided doses before or between meals. The dosage may be adjusted according to the patient's age and body weight, and symptoms.
(1) When TJ-33 is used, the patient’s “SHO” (constitution/symptoms) should be taken into account. The patient’s progress should be carefully monitored, and if no improvement in symptoms/findings is observed, continuous treatment should be avoided.
(2) When TJ-33 is coadministered with other Kampo- preparations (Japanese traditional herbal medicines), etc., attention should be paid to the duplication of the contained crude drugs. Special caution should be exercised when TJ-33 is coadministered with preparations containing Rhubarb.
(3) Since there is an individual difference in the cathartic action of Rhubarb, caution should be exercised concerning the dosage and administration.
SHO: The term “SHO” refers to a particular pathological status of a patient evaluated by the Kampo diagnosis, and is patterned according to the patient’s constitution, symptoms, etc. Kampo-preparations (Japanese traditional herbal medicines) should be used after confirmation that it is suitable for the identified “SHO” of the patient.